overig NICE backtracks to recommend Roche’s Gazyvaro in follicular lymphoma 13 februari 2018Pharmafile
overig Prostate cancer shake-up looms with new data from Pfizer, Astellas and Johnson & Johnson 9 februari 2018FiercePharma
